US 7300654
Method of treating corneal transplant rejection in high risk keratoplasty patients
granted A61KA61K31/00A61K31/7088
Quick answer
US patent 7300654 (Method of treating corneal transplant rejection in high risk keratoplasty patients) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/00, A61K31/7088, A61K45/06